3'- O- ((6- (2- nitro- 4- azidophenylamino)hexyl)carbamoyl)quercitrin

photoaffinity inhibitor of aldose reductase

Also Known As:

N-(2-nitro-4-azidophenyl)hexamethylenediamine-N'-(3'-O-quercitrin); NAP-HEX-Q

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Cataract (Cataracts) 01/01/1986 - "NAP-HEX-Q is designed as a drug to prevent or reverse diabetic cataract formation by selective photoaffinity inhibition of RLAR with no significant effect on aldose reductase in other tissues. "

1.	Aldehyde Reductase (Aldose Reductase)